---
title: "YOTRIO released its performance for the first half of the year, with a net profit attributable to the parent company of 513 million yuan, an increase of 0.88%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254417155.md"
description: "According to the Zhitong Finance APP, YOTRIO released its semi-annual report for 2025, with operating revenue of 3.08 billion yuan, a year-on-year increase of 3.34%. The net profit attributable to shareholders of the listed company was 513 million yuan, a year-on-year increase of 0.88%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 315 million yuan, a year-on-year increase of 19.99%. The basic earnings per share were 0.24 yuan"
datetime: "2025-08-25T10:40:07.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254417155.md)
  - [en](https://longbridge.com/en/news/254417155.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254417155.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/254417155.md) | [繁體中文](https://longbridge.com/zh-HK/news/254417155.md)


# YOTRIO released its performance for the first half of the year, with a net profit attributable to the parent company of 513 million yuan, an increase of 0.88%

According to the Zhitong Finance APP, YOTRIO (002489.SZ) released its semi-annual report for 2025, reporting an operating income of 3.08 billion yuan, a year-on-year increase of 3.34%. The net profit attributable to shareholders of the listed company was 513 million yuan, a year-on-year increase of 0.88%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 315 million yuan, a year-on-year increase of 19.99%. The basic earnings per share were 0.24 yuan

### Related Stocks

- [YOTRIO (002489.CN)](https://longbridge.com/en/quote/002489.CN.md)

## Related News & Research

- [A Look At Star Plus Legend Holdings’ Valuation As Guidance Swings From Profit To Loss](https://longbridge.com/en/news/279105880.md)
- [Fosun Pharma Unit Gets China Nod for Hematological Malignancy Drug Trial](https://longbridge.com/en/news/279052280.md)
- [Xprize founder Peter Diamandis launches new contest to manifest a new Star Trek](https://longbridge.com/en/news/278419951.md)
- [04:00 ETTARRAN lanza la primera bicicleta de cola larga hiperintegrada](https://longbridge.com/en/news/278842863.md)
- [S&P downgrades Botswana as diamond sector faces global headwinds](https://longbridge.com/en/news/279097271.md)